New patent for HIKMA PHENYLEPHRINE HYDROCHLORIDE – DrugPatentWatch
Expired Annual Drug Patent for PHENYLEPHRINE+HYDROCHLORIDE
Phenylephrine Hydrochloride is a drug marketed by Akorn, Mankind Pharma, Paragon Bioteck, Accord Hlthcare, Amneal, Caplin, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Meitheal, Par Sterile Products, Provepharm Sas, Sagent Pharms Inc, Sandoz Inc , and Pharm Assoc and, and are included in twenty-three NDAs. It is available from twenty five suppliers. There is one patent protecting this drug.
Drug patent litigation for PHENYLEPHRINE HYDROCHLORIDE.
This drug has one patent family member in one country.
The generic ingredient in PHENYLEPHRINE HYDROCHLORIDE is phenylephrine hydrochloride; promethazine hydrochloride. Twenty-five registered suppliers for this complex. Additional details are available on phenylephrine hydrochloride; promethazine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for the drug HIKMA PHENYLEPHRINE HYDROCHLORIDE
